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Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-
limited settings. We invited 27 ART programmes from urban settings in Africa, Asia and South America to
participate in a survey, with the aim to examine what preventive services had been integrated in ART programmes.
Twenty-two programmes participated; eight (36%) from South Africa, two from Brazil, two from Zambia and one
each from Argentina, India, Thailand, Botswana, Ivory Coast, Malawi, Morocco, Uganda and Zimbabwe and one
occupational programme of a brewery company included five countries (Nigeria, Republic of Congo, Democratic
Republic of Congo, Rwanda and Burundi). Twenty-one sites (96%) provided health education and social support,
and 18 (82%) provided HIV testing and counselling. All sites encouraged disclosure of HIV infection to spouses
and partners, but only 11 (50%) had a protocol for partner notification. Twenty-one sites (96%) supplied male
condoms, seven(32%) femalecondoms and20 (91%) provided prophylacticART for the prevention of mother-to-
child transmission. Seven sites (33%) regularly screened for sexually transmitted infections (STI). Twelve sites
(55%) were involved in activities aimed at women or adolescents, and 10 sites (46%) in activities aimed at
serodiscordant couples. Stigma and discrimination, gender roles and funding constraints were perceived as the
main obstacles to effective prevention in ART programmes. We conclude that preventive services in ART
programmes in lower income countries focus on health education and the provision of social support and male
condoms. Strategies that might be equally or more important in this setting, including partner notification, prompt
diagnosis and treatment of STI and reduction of stigma in the community, have not been implemented widely.
Keywords: HIV/AIDS; antiretroviral therapy; prevention; partner notiﬁcation; serodiscordant couples
Introduction
HIV prevention efforts in high-income and low-
income settings have traditionally focused on reducing
the risk of HIV infection among HIV-negative indivi-
duals or in populations with unknown serostatus, and
concerns about stigma and negative social outcomes
related to knowledge of HIV status have been para-
mount (Bunnell, Mermin, & De Cock, 2006). HIV
testing services were not widely available, particularly
inresource-limitedsettings.Thissituationhaschanged
in recent years with the scaling-up of antiretroviral
therapy (ART) and HIV testing in low and middle-
income countries. Close to four million people with
HIV/AIDSwereestimatedtobereceivingtreatmentat
the end of 2008 (World Health Organization (WHO),
2009). Adherence to ART (Mills et al., 2006) and
immunological and virological response (Braitstein
et al., 2006; Keiser et al., 2008b) in resource-limited
countries equal or exceed that in high-income settings,
and a decline in mortality at the population level has
recently been observed in Malawi and South Africa
(Egger & Boulle, 2008; Jahn et al., 2008).
The scale-up of ART in resource-limited settings
is a major achievement, which is extending the lives of
many people with HIV/AIDS. It is however clear that
‘‘we cannot treat our way out of this epidemic’’: in the
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0absence of reductions in HIV incidence, ART pro-
grammes will not be able to keep up with the increas-
ing number of people in urgent need of treatment (De
Cock, 2006). The Global HIV Prevention Working
Group, a panel of public health experts, clinicians,
researchers and people affected by HIV/AIDS, the
WHO and other agencies have argued that expanded
access to ART offers new opportunities to strengthen
HIV prevention (Gayle & Lange, 2004; WHO, 2008b).
It is unclear to what extent preventive services have
been integrated in ART programmes in resource-
limitedsettings.Weaddressedthisquestioninasurvey
of treatment sites in Africa, Asia and South America.
Methods
We conducted an electronic survey of the 27 pro-
grammes that provide ART to adult patients in 13
countries in Africa, Asia and Latin America and
participate in the ART in Lower Income Countries
(ART-LINC) collaboration, which is part of the
International epidemiological Databases to Evaluate
AIDS (IeDEA). The collaboration has been described
in detail elsewhere (Dabis et al., 2005; Keiser et al.,
2008a). Briefly, it was set up in 2003 with the aims of
defining the prognosis of HIV-infected patients
treated with ART in resource-limited settings and to
compare the experience between different settings,
delivery modes and types of monitoring. Potentially
eligible sites were identified in 2003 by screening
abstracts of international conferences, performing
MEDLINE searches and through personal contacts.
A total of 31 centres were contacted. To be eligible,
centres needed to prospectively collect information
on patients treated with ART. The ethics committees
or institutional review boards of all participating sites
approved participation in ART-LINC of IeDEA.
Questionnaire development, testing and implementation
The study was discussed with the Steering Committee
of ART-LINC, and all collaborators were invited to
comment on draft questionnaires. Item generation
involved the compilation of a comprehensive list of
relevant recommendations on HIV-prevention in
HIV-infected people (‘‘positive prevention’’). We
performed searches in MEDLINE (Pubmed version)
without language restrictions to identify relevant
articles in May 2007 and updated searches in July
2008. We checked the citations to five key articles
(Allen et al., 1992; Kalichman et al., 2001; Marks,
Burris, & Peterman, 1999; Oxman et al., 1994; Rao
et al., 1991) in the Science Citation Index (ISI Web of
Science). We also checked the reference lists of
relevant articles, contacted experts and incorporated
suggestions proposed by the steering committee of the
collaboration. We then selected the items we con-
sidered relevant to the settings represented in ART-
LINC, formulated questions and organised them in
different sections. We provided space to allow
respondents to comment. The questionnaire was pilot
tested and further changes were made.
The final version consisted of 140 close-ended and
54open-endedquestionsrelatingtothesite,theperson
completing the questionnaire and the prevention
services and other relevant activities implemented by
the programme. The content of the questionnaire,
whichisavailableonrequest,issummarisedinTable1.
Table 1. Content of questionnaire.
Topic
Total no of questions (no.
of open-ended questions)
Contact information and
characteristics of person
completing questionnaire
6 (4)
Health education
Content, type and staff
involved
49 (7)
Psychosocial support
Type of support, mode of
delivery, staff involved
36 (11)
Disclosure, counselling and testing, and partner
notification
Support of disclosure, type
of counselling and
testing, procedures for
partner notification
35 (8)
Prevention of mother-to-child transmission (PMTCT)
and other interventions for special groups
Protocols and drugs for
PMTCT, breastfeeding,
services targeted at
special groups
a
37 (13)
Provision of condoms and other contraception
Male and female condoms,
type of other
contraception provided
12 (3)
Other questions
Screening for sexually
transmitted infections,
activities to reduce stigma
and discrimination of
HIV-infected people,
obstacles to implementing
interventions
19 (8)
aMen who have sex with men (MSM), women, serodiscordant
couples, ethnic minorities, immigrants, adolescents, intravenous
drug users (IVDU), sex workers.
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2008 in DataCol (Data Collector), a web-based tool
developed by WHO to create electronic surveys and
forms (WHO, 2008a). The data are stored in a WHO-
maintained database that is regularly backed up.
Respondents downloaded the questionnaire as an
executable file, completed it on-line or off-line and
sent it back to the data centre at University of Bern.
Statistical analysis
Answers to open-ended questions were summarised
and coded where appropriate. We used univariable,
unweighted logistic regression analysis to explore
whether programme characteristics influenced the
availability of preventive services. We considered
the type of programme (government versus non-
governmental organisations or private clinic), access
to ART (free of charge versus fee-for-service) and
work load (scale-up cohorts with rapid increase in
patient numbers in recent years versus cohorts with
stable patient numbers). Dependent variables were
whether or not the programme had a protocol for
partner notification, whether or not it routinely
screened for sexually transmitted infections (STI) in
asymptomatic patients and whether dedicated ser-
vices for adolescents or serodiscordant couples were
available. Most countries contributed one site only,
which precluded analyses of country characteristics.
Results are presented as number of sites (%) or odds
ratios (ORs) with 95% confidence intervals (CIs). All
analyses were done with STATA version 10 (Stata
Corp; College Station, TX).
Results
Twenty-two of 27 sites returned the questionnaire
(response rate 82%). The questionnaire was com-
pleted by the clinical director in 15 sites (68%), by
researchers in five sites (23%) and by clinic managers
in two sites (9%). Nine respondents were female
(41%) and 13 were male (59%).
The characteristics of sites are summarised in
Table 2. Eight sites (36%) were located in South
Africa, two in Brazil, two in Zambia and one each
in Argentina, India, Thailand, Botswana, Ivory
Coast, Malawi, Morocco, Uganda and Zimbabwe
and one occupational programme of a brewery
company included five countries (Nigeria, Republic
of Congo, Democratic Republic of Congo, Rwanda
and Burundi). This programme was standardised
across sites and was therefore treated as a single
site. All 22 sites were located in urban areas, 19 were
specialised ART clinics and three sites (two occupa-
tional clinics and a private clinic) also functioned as
general practices. Sixteen programmes (73%) were
public and government-funded and six were run by
non-governmental organisations. Sixteen sites (73%)
provided ART free of charge (Table 2). The five sites
that did not participate included one smaller research
cohort in Senegal and four scale-up cohorts in
Botswana, Kenya, South Africa and Zambia.
Health education, condoms and other interventions
Health education was provided by 21 of the 22 sites
(96%). Table 3 details the topics covered: most
programmes addressed the routes of transmission,
prevention of sexual transmission by male condoms
and prevention of mother-to-child transmission
(PMTCT). Other topics, for example, female con-
doms, were covered by fewer programmes. Health
education was delivered through talks in the waiting
area (17 sites, 81%), posters (15 sites, 71%) and flyers
(13 sites, 62%). Twenty-one sites (96%) provided
male condoms and seven (32%) female condoms.
Practical instructions on the correct use of male
condoms were provided by 12 sites (57%) and on
the use of female condoms by seven sites (33%).
Condoms were generally available free of charge.
Twelve sites (55%) provided injectable or oral contra-
ceptives. All sites provided post-exposure prophylaxis
(PEP) for staff, for example, after needle stick
injuries. No site provided clean needles or syringes
for intravenous drug users. Twenty-one sites (96%)
tested for STI but only 12 of these (57%) screened
asymptomatic patients at the first visit and seven
(33%) screened at regular intervals. Twenty sites
(91%) screened routinely for syphilis in pregnant
women. Point of care testing for syphilis was avail-
able in 15 sites (68%) and same day treatment in nine
of these 15 sites (60%).
Ten sites (46%) were involved in activities to
reduce poverty in HIV-infected patients, including,
for example, projects to generate income or support
to access social security grants. One programme was
involved in activities to reduce stigma associated with
HIV in the community, through marches, radio talks,
theatre or the distribution of T-shirts printed with the
words ‘‘HIV-positive’’.
Disclosure, counselling and testing and partner
notification
All sites encouraged patients to disclose their HIV test
resulttopartnersandspouses.Twenty-onesites(96%)
provided psychosocial support. This included counsel-
ling (21 sites, 100%), referral to self-help groups
(17 sites, 81%) and drop-in centres (four sites, 19%).
Issues addressed included financial problems, stress
management, coping strategies and the strengthening
AIDS Care 777
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0Table 2. Characteristics of the 22 antiretroviral therapy (ART) programmes included in the survey.
Region and country Site
Start of ART
provision
No. of HIV-infected
patients
No. of patients
on ART
Routine viral load
monitoring
Public
programme
Free access to
ART
Scale-up
cohort
a
Asia
Thailand A 2003 1000 314 Yes Yes No No
India B 1996 10,000 5800 No No Mixed
b Yes
South America
Argentina C 2003 3200 2500 Yes Yes Yes No
Brazil D 1996 2500 1100 Yes Yes Yes No
Brazil E 1996 2200 1500 Yes Yes Yes No
Africa
Morocco F 850 760 Yes Yes Yes No
Co ˆ te d’Ivoire G 1999 10,491 3393 No No No Yes
Uganda H 2001 6500 3300 Yes Yes Yes No
Botswana I 1990 3000 1750 Yes No No No
Malawi J 2002 7700 6284 No Yes Yes Yes
Zambia K 1997 300 100 Yes No No No
L 2003 1434 292 No Yes Yes No
Zimbabwe M 2004 1448 1157 No Yes Yes No
South Africa N 1996 4864 3065 Yes Yes No Yes
O 1999 13,349 10,119 Yes Yes Yes Yes
P 2004 979 939 Yes Yes Yes No
Q 2004 1350 683 Yes No Yes No
R 2001 6000 3000 Yes Yes Yes Yes
S 2002 3883 2400 Yes Yes Yes Yes
T 2004 1675 1133 Yes Yes Yes No
U 2003 1009 481 No Yes Yes No
Sites in several
countries
c
V 2001 393 277 Yes No Yes No
Median (range) 2001 (19962004) 2350 (30013,349) 1328 (10010,119)
Number with
characteristics (%)
16 (73%) 16 (73%) 16 (73%) 7 (32%)
aSites with increasing patient numbers over several years were considered scale-up cohorts.
bAbout 30% of patients have free access to ART.
cNigeria, Republic of Congo, Democratic Republic of Congo, Rwanda, Burundi.
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0of self-confidence. Eleven sites (52%) addressed gen-
der-based violence. Counselling and testing was avail-
able on site in 18 (82%) programmes. This included
voluntarycounsellingandtesting(VCT)at16ofthe18
sites (89%), couple counselling and testing in 15 sites
(83%)androutine,opt-out,testinginpregnantwomen
at11sites(61%).Elevensites(50%)hadaprotocolfor
managingpartnernotificationofHIV-infectedpeople;
most of them used the patient referral method, where
patients themselves inform sexual partners and ask
them to attend aclinic for counselling and testing. One
siteindicatedthattheyusedproviderreferralwherethe
health professional contacts the partner on behalf of
the patient, and two sites reported that they would
inform partners if the patient had not done so after a
certain period of time.
Prevention of mother-to-child transmission (PMTCT)
and other interventions targeted at specific groups
Twenty sites (91%) provided ART to prevent mother-
to-child transmission (Table 4). Regimens for the
mother varied widely. Nine sites (41%) provided triple
combination ART based on nevirapine (NVP) or
efavirenz. Other regimens included zidovudine (AZT)
from 28 weeks and single-dose NVP, dual therapy
with AZT and lamivudine (3TC) and single-dose NVP
in all women or in women with CD4 cell counts above
200 cells/mL. Similarly, in newborns, regimens in-
cluded single-dose NVP, single-dose NVP and AZT
for one week or one month. A minority of sites
(8, 36%) recommended elective caesarean section.
Most programmes (19, 86%) recommended
exclusive replacement feeding to prevent MTCT but
over half of them (11 of 19, 58%) also recommended
exclusive breastfeeding either followed by rapid
Table 3. Topics covered in health education activities
provided at 21 antiretroviral therapy (ART) programmes.
Topic
No. of sites (%)
addressing topic
General information about the virus,
course of the disease and therapy
21 (100%)
Routes of transmission 21 (100%)
Misperception about transmission 21 (100%)
Risk of transmission by
unprotected sex
21 (100%)
Risk of transmission by having
multiple sex partners
21 (100%)
Male condoms to prevent
transmission
21 (100%)
Prevention of mother-to-child
transmission (PMTCT)
20 (95.2%)
Risk of transmission through sex under
the influence of alcohol and other
substances
20 (95.2%)
Risk of transmission by blood
transfusions
18 (85.7%)
Influence of antiretroviral therapy on
transmission risk
18 (85.7%)
Abstinence to prevent transmission 18 (85.7%)
Monogamy to prevent transmission 17 (81.0%)
Contraception to prevent unplanned
pregnancy
17 (81.0%)
Risk of transmission by needle sharing 16 (76.2%)
Female condoms to prevent
transmission
15 (71.4%)
Role of post-exposure prophylaxis
(PEP)
14 (66.7%)
Vaginal microbicides to prevent trans-
mission
4 (19.0%)
Note: Table shows the number of sites that covered topic.
Percentages relate to the 21 sites that provided health education.
One out of 22 programmes did not provide health education.
Table 4. Interventions offered or promoted by 22 antire-
troviral therapy (ART) programmes to prevent mother to
child transmission (MTCT) during pregnancy and birth,
and after birth.
Measure
No. of sites (%)
providing measure
Prevention of MTCT during pregnancy and birth
Prophylactic antiretroviral
therapy
20 (90.9%)
Promotion of hospital
delivery
13 (59.1%)
Promotion of elective
caesarean section
8 (36.4%)
No specific measures in place 2 (9.1%)
Prevention of MTCT during breastfeeding
Promotion of exclusive
replacement feeding
a
19 (86.4%)
Promotion of six months
exclusive breastfeeding
followed by rapid weaning
7 (31.8%)
Promotion of six months
exclusive breastfeeding
followed by mixed feeding
5 (22.7%)
Provision of formula milk free
of charge
13 (59.1%)
Heat-treating breast-milk 1 (4.5%)
Antiretroviral therapy during
breastfeeding
1 (4.5%)
No specific measures in place 1 (4.5%)
aIf acceptable, feasible, affordable, sustainable and safe. Eleven of
these sites provided formula milk free of charge.
Note: Table shows the number of sites that provided the specific
measure. Percentages relate to the 22 sites that participated in
the survey. Interventions are not exclusive: a programme could
promote several interventions.
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Eleven of the 19 programmes (58%) provided for-
mula milk free of charge. With the exception of three
sites in South Africa and Botswana, 12 of the 15
programmes in sub-Saharan Africa (80%) recom-
mended six months of exclusive breastfeeding fol-
lowed by complementary feeding (five sites) or rapid
weaning (seven sites). Figure 1 shows the number of
sites involved in preventive services targeted at
different groups. In addition to PMTCT, 12 sites
(55%) were involved in activities aimed at women or
adolescents and 10 sites (46%) worked with serodis-
cordant couples. Few sites provided preventive ser-
vices to other groups.
Determinants of provision of preventive services
There were no statistically significant associations
with programme characteristics. There was some
evidence that partner notification protocols were
less likely to be in place in programmes not funded
through government (OR 0.39, 95% CI 0.062.8), in
programmes that charged patients for ART (OR
0.12, 95% CI 0.011.29) and in scale-up programmes
(OR 0.66, 95% CI 0.114.0). Regular screening for
STI tended to be less likely in scale-up cohorts
compared to other programmes (OR 0.30, 95% CI
0.033.3).
Obstacles
In an open-ended question, respondents were asked
to describe the main problems in implementing
preventive services in their programme. The ‘‘back-
ground of stigma, discrimination, blame’’ (female
respondent from Thailand) was considered a major
problem in implementing prevention services and
similar comments were made by six other respondents
from Argentina, India, South Africa and Zambia.
Another recurring theme was the very high patient
load ‘‘so there is often inadequate time for counsel-
ling’’ (female respondent from Zimbabwe) and finan-
cial constraints, ‘‘which prevent programmes from
hiring additional staff’’ (male respondent from Co ˆ te
d’Ivoire).
Discussion
Preventive services for HIV-positive people were
available in most of the ART programmes surveyed
in this study. The programmes focused on health
education aimed at changing behaviour of patients
and the provision of social support, male condoms
and of interventions to prevent transmission from
mothers to their newborns and infants. Fewer sites
had protocols for partner notification or offered
specific interventions for discordant couples, adoles-
cents and other groups at high risk. Moreover, only a
minority of sites regularly screened for STI and only
one site was involved in activities to reduce the stigma
and discrimination associated with HIV infection.
Our survey predates the publication of WHO’s
recommendations on essential prevention interven-
tions (WHO, 2008b) but it covered many of the
recommended interventions and may thus serve as a
baseline to assess progress with integrating interven-
tions in ART programmes. Our study has several
limitations, however. The clinics and programmes
that participate in ART-LINC of IeDEA are not
representative of all sites providing ART in the
countries studied, being mainly urban and having
electronic databases for data capture (Forster et al.,
2008). The provision of preventive services, or the
lack thereof, was not, however, a criterion for
inclusion in the ART-LINC collaboration. In addi-
tion, many of the countries that are scaling-up ART
were represented in the survey. The data were self-
reported and results might have been affected by
social desirability bias. This seems unlikely consider-
ing that sites have been collaborating for several years
and helped design the study. Finally, the quality of
preventive services was not assessed.
Although VCT was provided by most sites, only a
minority of programmes reported specific interven-
tions targeted at discordant couples. Discordant
couples represent an important target for HIV-1
prevention, particularly in sub-Saharan Africa, where
most transmissions occur among discordant couples
who are unaware of their serostatus (Gayle & Lange,
2004; Piot, Bartos, Larson, Zewdie, & Mane, 2008).
ART programmes are in an ideal position to identify
discordant couples and deliver interventions. A trial
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Figure 1. Number of sites involved in preventive services
aimed at speciﬁc target groups.
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0in Kenya, Tanzania and Trinidad, which randomly
assigned couples to VCT or basic health education,
found that couples assigned to counselling and testing
reduced unprotected intercourse more than couples
assigned to health education (The Voluntary HIV-1
Counseling and Testing Efficacy Study Group, 2000).
Providing advice ondisclosing to sexual partners is
part of the testing and counselling process. There is
thereforesubstantialoverlapwithpartnernotification,
in which the partners of people with STI are informed
of their exposure (Hogben, McNally, McPheeters, &
Hutchinson, 2007; Mathews et al., 2001), but only half
of programmes had protocols for partner notification.
Partner notification for HIV infection has also been
difficult to implement in industrialised countries,
where it is sometimes viewed as a coercive public
health intervention that conflicts with protecting the
individual’s right to privacy, especially before the
widespread introduction of ART (Golden, Faxelid,
& Low, 2008). The diagnosed person might experience
negative events including relationship breakdown or
physical violence (Grinstead, Gregorich, Choi, &
Coates, 2001; Hogben et al., 2007). The terminology
of personalised risk reduction in a client-centred
approach might have facilitated the acceptance of
VCT services for HIV infection. The benefits of
involving patients with other STI in informing their
partners are becoming increasingly recognised (Trelle,
Shang, Nartey, Cassell, & Low, 2007). Sharing suc-
cessful approaches to VCT and partner notification
interventions may thus contribute to improving the
control of all STI. Clearly, either intervention should
only be offered if the support needed to help newly
diagnosed people, and particularly women, to cope
with their disease is also available. It is reassuring that
most sites provided such support.
Few sites offered services that covered several or
all components of PMTCT, including the prevention
of infection in HIV-negative women, of unwanted
pregnancies and of transmission to the offspring
during pregnancy, birth and breastfeeding (Piot
et al., 2008; Dabis & Ekpini, 2002). Only 12 sites
(55%) provided contraception other than condoms.
The prevention of unwanted pregnancies as an
important primary prevention strategy does not
appear to have been widely implemented. Also,
recommendations and drug regimens for the preven-
tion of transmission to neonates and infants varied
widely. This may be a reflection of the complexity of
current guidelines (WHO, 2006) but some of the
variation must be of concern: not all sites system-
atically provided suppressive triple combination
ART to pregnant women with indications for ART,
a strategy that is safe, highly effective and unequi-
vocally recommended by WHO (WHO, 2006).
Our study is relevant to the debate on whether
infants of HIV-infected women in resource-limited
settings should be breastfed or formula fed (Cout-
soudis, Goga, Rollins, & Coovadia, 2002; Mofenson
& McIntyre, 2000). HIV transmission to infants
occurs through breastfeeding but exclusive breast-
feeding for the first few months of life is associated
with lower transmission rates than is complementary
feeding (Coovadia et al., 2007; Iliff et al., 2005).
Formula feeding substantially increases the risk of
death due to diarrhoea, acute respiratory infections
and other infectious diseases (WHO Collaborative
Study Team on the Role of Breastfeeding on the
Prevention of Infant Mortality, 2000). The updated
WHO guidelines (WHO, 2007), therefore, stress that
although formula feeding may be the right choice for
some HIV-infected women, exclusive breastfeeding
for the first six months is the gold standard for the
babies of HIV-infected mothers who live in resource-
poor settings and cannot supply replacement feeding
safely (Coutsoudis, Coovadia, & Wilfert, 2008). In
keeping with these guidelines recommendations and
practices differed across sites, and differed within the
same country, for example in South Africa, where
large disparities in socio-economic status and infant
mortality rates exist. It nevertheless appears that the
updated guidelines may not yet have been widely
implemented: nine sites (41%) promoted rapid wean-
ing, which is not recommended by the guidelines
(WHO, 2007).
Our respondents stressed that stigma and discri-
mination at the level of the community, high patient
load and financial constraints were important ob-
stacles for the implementation of preventive services
in ART programmes. The Global HIV Prevention
Working Group (Gayle & Lange, 2004) and other
agencies have argued that staff of ART programmes
should be trained to deliver prevention services. In
particular, ART programmes should actively address
and reduce discrimination of HIV-infected people in
the communities they serve. Piot and colleagues
called for a coalition of youth, women’s and religious
organisations, as well as business leaders and HIV/
AIDS activists to create a newly energised HIV
prevention movement (Piot et al., 2008). By making
effective treatment and appropriate prevention ser-
vices available, ART programmes can make impor-
tant contributions to both prevention and the
expansion of access to ART. Treatment programmes
should not operate in isolation but need to be part of,
and supported by, the prevention constituency.
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